Food and Chemical Toxicology 37, 10431053 (1999)
In the REWIND trial, dulaglutide cut major heart events by 12%, proving GLP-1s protect the heart, not just blood sugar
A recent real-world study from Virta Health found that individuals with type 2 diabetes who discontinued GLP-1 therapy while continuing a ketogenic or low-carb diet maintained their weight loss over 12 months, with more than 70% sustaining at least 5% weight loss
Reconstitute a GLOW-70 vial by adding 2.5 mL of BAC water That delivers a concentration of 28 mg/mL The resulting dose per injection: 2.8 mg 28 mg/mL = 0.1 mL or 10-units on a U-100 insulin syringe Each 70 mg vial of GLOW supplies 25 daily doses and remains within the 28-day refrigerated-use window
EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching
Although supplementation is not proven to be effective, taking glutathione and consuming foods that are rich in this antioxidant can be helpful
